Shield Therapeutics

Shield Therapeutics is a commercial-stage specialty pharmaceutical company. It provides innovative specialty drugs to meet significant unmet needs in the treatment of iron deficiency and hyperphosphatemia. Our lead product Feraccru®/Accrufer® is a novel, stable, salt-free oral therapy approved in the United States, the European Union, the United Kingdom, and Switzerland for the treatment of iron deficiency in adults with or without anemia.